Atlas Trials

Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

Clinical trial NCT01516515 · COMPLETED

Trial details

NCT number
NCT01516515
Sponsor
G&E Herbal Biotechnology Co., LTD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Actinic Keratosis
Start date
2013-02-01
Primary completion
2017-12-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.